Abstract

Introduction.– Tools have been developed to identify potentially inappropriatemedications (PIM) in elderly, aswell as potential prescribing omissions (PPO). The purpose of the study was to analyze the therapeutic appropriateness in the hospitalized elderly. Methods.– Were retrospectively selected 150 patients, with ≥65years, admitted to InternalMedicineward, between 1 July and 31 December, 2011. Thirty-three were excluded. The Beers criteria (2012), STOPP and START were applied at admission and clinical discharge. Results.–Onehundredand seventeenpatientswere analyzed.Mean age: 81.2 years. Average drugs per patient: 7.2 at admission, 6.8 at discharge. Major polypharmacy (≥5 drugs): 81.2% at admission; 82.9% at discharge. In the Beers criteria, were detected at admission 127 PIM (1.09/patient), and 125 PIM (1.07/patient) at discharge, of which 38.9% and 48.0% respectively were benzodiazepines (BZD). PIM due to drug–disease/syndrome interactions: 80 at entrance, 73 at discharge, especially in dementia (37.5% and 39.7% respectively). PIM to be usedwith caution: 83 at entrance, 74 at discharge. STOPP criteria: detected 143 PIM (1.22/patient) at admission and 113 (0.97/patient) at discharge, representing a decrease of 30 PIM. The long-term BZD represented 26.6% of PIM at entrance and 38.9% at discharge. START criteria detected 195 PPO (1.67/patient), 38.5% were regarding to cardiovascular system; occurring a decrease of 42.1% PPO at discharge. Conclusions.– The tools identified a significant number of PPO and PIM. Their use can contribute to reduce adverse drug events in the elderly and their associated costs.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.